Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Clinical trial NCT01083316 · COMPLETED
Trial details
- NCT number
- NCT01083316
- Sponsor
- Boston Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.